Clinical Trials Directory

Trials / Completed

CompletedNCT00821002

A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

An Open-Label, Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Mati Therapeutics Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study objective is to compare IOP and safety outcomes based on plug placement (upper or lower puncta).

Conditions

Interventions

TypeNameDescription
DRUGLatanoprostComparison of punctal plug placement between upper and lower puncta

Timeline

Start date
2009-01-01
Primary completion
2009-11-01
Completion
2009-11-01
First posted
2009-01-12
Last updated
2013-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00821002. Inclusion in this directory is not an endorsement.